Cysteine is a cardiovascular risk factor in hyperlipidemic patients

Citation
N. Jacob et al., Cysteine is a cardiovascular risk factor in hyperlipidemic patients, ATHEROSCLER, 146(1), 1999, pp. 53-59
Citations number
53
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
146
Issue
1
Year of publication
1999
Pages
53 - 59
Database
ISI
SICI code
0021-9150(199909)146:1<53:CIACRF>2.0.ZU;2-P
Abstract
Several studies have reported that moderate hyperhomocysteinemia is related to an increased risk for atherosclerosis, but few data are available with regard to any other thiol compound having a potential vascular toxicity. Th erefore, we measured both total cysteine and homocysteine plasma levels in patients with hyperlipidemia (242 males and 147 females, 41-65 years old). Homocysteine was higher in males than in females, 13.2 +/- 4.1 versus 11.1 +/- 3.4 mu mol/l (P < 0.0001). The mean cysteine level was 243.3 +/- 45.7 m u mol/l in the whole study population. The subjects were split in two group s, symptomatic patients with cardiovascular disease (n = 106) and asymptoma tic subjects (n = 283). Blood pressure, smoking status, total cholesterol, LDL-cholesterol and triglycerides did not statistically differ between grou ps, but the mean HDL-cholesterol level was lower in symptomatic patients (1 .24 +/- 0.38 versus 1.42 +/- 0.41, P < 0.0001). Cysteine levels were high i n patients with cardiovascular disease than in asymptomatic patients, respe ctively 254.7 +/- 47.7 versus 239.1 +/- 44.3 mu mol/l (P = 0.003). A simila r result was found for homocysteine, respectively 13.1 +/- 4.3 versus 12.2 +/- 3.9 mu mol/l (P = 0.05). To analyse whether cysteine levels were relate d to atherosclerosis independently of age, adjusted levels were compared be tween asymptomatic patients with normal carotid arteries (n = 176), carotid atherosclerosis (n = 107) and symptomatic patients (n = 106). Age adjusted cysteine levels differed significantly between groups (P = 0.027) while th e P-value was of borderline significance for homocysteine (P = 0.09). Odds ratios for having symptomatic cardiovascular disease were 1.81 (95% CI, 1.0 2-3.21) and 2.05 (95% CI, 1.16-3.60) for the mid and highest tertiles of cy steine using the lowest as the reference. After adjustment in a multivariat e model including age, sex, and creatinine, the odds ratio for disease rema ined significant between the highest tertile versus the lowest (OR = 1.89). Adjusted odds ratios were found to be weaker when homocysteine tertiles we re compared. Our data suggest that plasma total cysteine is a risk factor f or atherosclerosis in hyperlipidemic patients. (C) 1999 Elsevier Science Ir eland Ltd. All rights reserved.